Investigation of Hypertension in Childhood

Comprehensive Pediatric Nephrology

Volumn , Issue , 2008, Pages 645-663

  Hadtstein, Charlotte ^a   Wühl, Elke ^a  

^a Center for Pediatrics and Adolescent Medicine   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84878858769     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-04883-5.50048-9     Document Type: Chapter

References (106)

1. Chobanian AV, Barkis GL, Black DL, Cushman WC, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 Report. JAMA 2003, 289(19):2560-2571.
2. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 1999, 17:151-183.
3. Williams B, Poulter NR, Brown MJ, Davis M, et al. The BHS Guidelines Working Party guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society. J Hum Hypertens 2004, 18:139-185.
4. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004, 114:555-576. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents.
5. Cuspidi C, Meani S, Fusi V, Valerio C, et al. Isolated ambulatory hypertension and changes in target organ damage in treated hypertensive patients. J Hum Hypertens 2005, 19:471-477.
6. Canzanello VJ, Jensen PL, Schwartz GL Are aneroid sphygmoma-nometers accurate in hospital and clinic settings?. Arch Intern Med 2001, 161:729-731.
7. Bailey RH, Knaus VL, Bauer JH Aneroid sphygmomanometers. An assessment of accuracy at a university hospital and clinics. Arch Intern Med 1991, 151:1409-1412.
8. Yarows SA, Qian K Accuracy of aneroid sphygmomanometers in clinical usage: University of Michigan experience. Blood Press Monit 2001, 6:101-106.
9. Hussain A, Cox JG An audit of the use of sphygmomanometers. Br J Clin Pract 1996, 50:124.
10. Update on the 1987 task force report on high blood pressure in children and adolescents: a working group report from the national high blood pressure educational program. Pediatrics 1996, 98(4):649-658. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents.
11. Graves JW, Bailey KR, Grossardt BR, Gullerud RE, et al. The impact of observer and patient factors on the occurrence of digit preference for zero in blood pressure measurement in a hypertension specialty clinic: evidence for the need of continued observation. Am J Hypertens 2006, 19:567-572.
12. Nietert PJ, Wessell AM, Feifer C, Ornstein SM Effect of terminal digit preference on blood pressure measurement and treatment in primary care. Am J Hypertens 2006, 19:147-152.
13. Wingfield D, Cooke J, Thijs L, Staessen JA, et al. Terminal digit preference and single-number preference in the Syst-Eur trial: influence of quality control. Blood Press Monit 2002, 7:169-177.
14. Wright BM, Dore CF A random-zero sphygmomanometer. Lancet 1970, 1:337-338.
15. O'Brien E, Petrie J, Littler W, de Swiet M, et al. The British Hypertension Society protocol for the evaluation of automated and semi-automated blood pressure measuring devices with special reference to ambulatory systems. J Hypertens 1990, 8:607-619.
16. American National Standard Institution (ANSI)/Association for the Advancement of Medical Instrumentation (AAMI): SP10:20022- manual, electronic or automated sphygmomanometers, 2003.
17. O'Brien E, Pickering T, Asmar R, Myers M, et al. Working Group on Blood Pressure Monitoring of the European Society of Hypertension International Protocol for validation of blood pressure measuring devices in adults. Blood Press Monit 2002, 7:3-17.
18. Park MK, Menard SM, Schoolfield J Oscillometric blood pressure standards for children. Pediatr Cardiol 2005, 26:601-607.
19. Park MK, Menard SM Normative oscillometric blood pressure values in the first 5 years in an office setting. Am J Dis Child 1989, 143(7):860-864.
20. Stergiou GS, Efstathiou SP, Argyraki CK, Gantzarou AP, et al. Clinic, home and ambulatory pulse pressure: comparison and reproducibility. J Hypertens 2002, 20:1987-1993.
21. Stergiou GS, Alamara CV, Salgami EV, Vaindirlis IN, et al. Reproducibility of home and ambulatory blood pressure in children and adolescents. Blood Press Monit 2005, 10:143-147.
22. Toumanidis S, Stabouli S, Kotsis V, Toumanidis S, et al. White-coat and masked hypertension in children: association with target organ damage. Pediatr Nephrol 2005, 20:1151-1155.
23. Hornsby JL, Morgan PF, Taylor AT, Treibner FA White coat hypertension in children. J Fam Pract 1991, 3:617-623.
24. Sorof JM, Portman RJ White coat hypertension in children with elevated casual blood pressure. J Pediatr 2000, 137:493-497.
25. Matsuoka S, Kawamura K, Honda M, Awazu M White coat effect and white coat hypertension in pediatric patients. Pediatr Nephrol 2002, 17:950-953.
26. Vollmer WM, Appel LJ, Svetkey LP, Moore TJ, et al. Comparing office-based and ambulatory blood pressure monitoring in clinical trials. J Hum Hypertens 2005, 19:77-82.
27. Ogedegbe G, Schoenthaler A A systematic review of the effects of home blood pressure monitoring on medication adherence. J Clin Hypertens (Greenwich) 2006, 8:174-180.
28. Staessen JA, Den Hond E, Celis H, Fagard R, et al. Antihypertensive treatment based on blood pressure measurement at home or in the physician's office: a randomized controlled trial. JAMA 2004, 291:955-964.
29. Nordman A, Frach B, Walker T, Martina B Comparison of self-reported home blood pressure measurements with automatically stored values and ambulatory blood pressure. Blood Press 2000, 9(4):200-205.
30. Wühl E, Hadtstein C, Mehls O, Schaefer F Home, clinic, and ambulatory blood pressure monitoring in children with chronic renal failure. Pediatr Res 2004, 55:492-497. ESCAPE Trial Group.
31. Stergiou GS, Yiannes NG, Rarra VC, Panagiotakos DB Home blood pressure normalcy in children and adolescents: The Arsakeion School Study. J Hypertens 2007, 25:1375-1379.
32. O'Sullivan JJ, Derrick G, Griggs P, Foxall R, et al. Ambulatory blood pressure in schoolchildren. Arch Dis Child 1999, 80:529-532.
33. Soergel M, Kirschstein M, Busch C, Danne T, et al. Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: a multicenter trial including 1141 subjects. J Pediatr 1997, 130:178-184.
34. Wühl E, Witte K, Soergel M, Mehls O, Schaefer F Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. German Working Group on Pediatric Hypertension. J Hypertens 2002, 20(10):1995-2007.
35. Bald M, Kubel S, Rascher W Validity and reliability of 24h blood pressure monitoring in children and adolescents using a portable, oscillometric device. J Hum Hypertens 1994, 8:363-366.
36. Owens P, Atkins N, O'Brien E Diagnosis of white coat hypertension by ambulatory blood pressure monitoring. Hypertension 1999, 34:267-272.
37. Staessen JA, Thijs L, Fagard B, O'Brien ET, et al. Predicting cardiovascular risk using conventional ambulatory blood pressure in older patients with systolic hypertension. JAMA 1999, 282:539-546.
38. Clement DL, de Buyzere ML, de Bacquer DA, de Leeuw PW, et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension, N. Engl J Med 2004, 348(24):2407-2415.
39. Sega R, Facchetti R, Bombelli M, Cesana G, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Artereiose Monitorate e Loro Asssociazioni (PAMELA) study. Circulation 2005, 111:1777-1783.
40. Sorof JM, Cardwell G, Franco K, Portman RJ Ambulatory blood pressure and left ventricular mass index in hypertensive children. Hypertension 2002, 39:903-908.
41. Palatini P Too much of a good thing? A critique of overemphasis on the use of ambulatory blood pressure monitoring in clinical practice. J Hypertens 2002, 20:1917-1923.
42. Profant J, Dimsdale JE Race and diurnal blood pressure patterns. A review and meta-analysis. Hypertension 1999, 33:1099-1104.
43. Park MK, Menard SM, Yuan C Comparison of blood pressure in children from three ethnic groups. Am J Cardiol 2001, 87:1305-1308.
44. Baron AE, Freyer B, Fixler DE Longitudinal blood pressure in blacks, whites, and Mexican Americans during adolescence and early adulthood. Am J Epidemiol 1986, 123:809-817.
45. Liu M, Takahashi H, Morita Y, Maruyama S, et al. Non-dipping is a potent predictor of cardiovascular mortality and is associated with autonomic dysfunction in haemodialysis patients. Nephrol Dial Transplant 2003, 18:563-569.
46. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens 2002, 20(11):2183-2189.
47. Farmer CKT, Goldsmith DJA, Cox J, Dallyn P, et al. An investigation of the effects of advancing uraemia, renal replacement therapy and renal transplantation on blood pressure variability. Nephrol Dial Transplant 1997, 12:2301-2307.
48. Timio M, Venanzi S "Non-dipper" hypertensive patients and progressive renal insufficiency: a 3-year longitudinal study. Clin Nephrol 1995, 43(6):382-387.
49. Dustan HP, Gifford RW, Frohlich ED The 1984 report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1984, 144:1045-1057. Joint National Committee on Prevention Detection Evaluation and Treatment of High Blood Pressure.
50. Sheps SG, Black H, Cohen JD The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997, 157:2413-2446. Joint National Committee on Prevention Detection Evaluation and Treatment of High Blood Pressure.
51. Task Force on Blood Pressure Control in Children: report of the Task Force on Blood Pressure Control in Children. Pediatrics 1977, 59(5):795-820.
52. Muntner P, He J, Cutler JA, Wildman RP, Whelton PK Trends in blood pressure among children and adolescents. JAMA 2004, 291:2107-2113.
53. Staessen JA, Asmar R, de Buyzere ML, Imai Y, et al. Task Force II: blood pressure measurement and cardiovascular outcome. Blood Press Monit 2001, 6:355-370.
54. de Man SA, André JL, Bachmann HJ, Grobbee DE, et al. Blood pressure in childhood: pooled findings of six European studies. J Hypertens 1991, 9:109-114.
55. Report of the second task force on blood pressure control in children-1987. Pediatrics 1987, 97(1):1-25. Task Force on Blood Pressure Control in Children.
56. Park MK, Lee DH Normative arm and calf blood pressure values in the newborn. Pediatrics 1989, 83:240-243.
57. Mancia G, Sega R, Bravi C, De Vito G, et al. Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens 1995, 13:1377-1390.
58. White WB, Dey HM, Schulman P Average daily blood pressure load as determinant of cardiac function in patients with mild to moderate hypertension. Am Heart J 1989, 118:782-795.
59. White WB, Schulman P, McCabe EJ, Dey HM Average daily blood pressure, not office blood pressure, determines cardiac function in patients with hypertension. JAMA 1989, 261:873-877.
60. Nehal US, Ingelfinger JR Pediatric hypertension: recent literature. Curr Opin Pediatr 2002, 14:189-196.
61. Koshy S, Macarthur C, Luthra S, Gajaria M, Geary D Ambulatory blood pressure monitoring: mean blood pressure and blood pressure load. Pediatr Nephrol 2005, 20:1484-1486.
62. Angeli F, Verdeccia P, Gattobigio R, Saradone M, Reboldi G White coat hypertension in adults. Blood Press Monit 2005, 10:301-305.
63. Stergiou GS, Yiannes NJ, Rarra VC, Alamara CV White-coat hypertension and masked hypertension in children. Blood Press Monit 2005, 10:297-300.
64. Lurbe E, Torro I, Alvarez V, Nawrot T, et al. Prevalence, persistence and clinical significance of masked hypertension in youth. Hypertension 2005, 45:493-498.
65. Swinford RD, Portman RJ Diagnostic evaluation of pediatric hypertension. Pediatric hypertension 2004, 405-420. Humana Press, Totowa, NJ. R.J. Portman, J.M. Sorof, J.R. Ingelfinger (Eds.).
66. Wingen AM, Fabian Bach C, Schaefer F, Mehls O European Study Group for Nutritional Treatment of Chronic Renal Failure in Child hood: Randomised multicentre study of a low-protein diet on the progression of chronic renal failure in children. Lancet 1997, 349(9059):1117-1123.
67. Lurbe E, Thijs L, Redon J, Alvarez V, et al. Diurnal blood pressure curve in children and adolescents. J Hypertens 1995, 14:41-46.
68. Portaluppi F, Montanari L, Ferlini M, Gilli P Altered circadian rhythms of blood pressure and heart rate in non-hemodialysis chronic renal failure. Chronobiol Int 1990, 7(4):321-327.
69. Carvalho MJ, van den Meiracker AH, Boomsma F, Lima M, et al. Diurnal blood pressure variation in progressive autonomic failure. Hypertension 2000, 35(4):892-897.
70. Narkiewicz K, Winnicki M, Schroeder K, Phillips BG, et al. Relationship between muscle sympathetic nerve activity and diurnal blood pressure profile. Hypertension 2002, 39(1):168-172.
71. Lurbe E, Redon J, Liao Y, Tacons J, et al. Ambulatory blood pressure monitoring in normotensive children. J Hypertens 1994, 12:1417-1423.
72. Wühl E, Hadtstein C, Mehls O, Schaefer F Ultradian but not circadian blood pressure rhythms correlate with renal dysfunction in children with chronic renal failure. J Am Soc Nephrol 2005, 16:746-754. ESCAPE Trial Group.
73. Sander D, Kukla C, Klingelhofer J, Winbeck K, Conrad B Relationship between circadian blood pressure patterns and progression of early carotid atherosclerosis: a 3-year follow-up study. Circulation 2000, 102:1536-1541.
74. Kikuya M, Hozawa A, Ohokubo T, Tsuji I, et al. Prognostic significance of blood pressure and heart rate variabilities. The Ohasama Study. Hypertension 2000, 36:901-906.
75. Dillon MJ, Ryness JM Plasma renin activity and aldosterone concentration in children. BMJ 1975, 5992:316-319.
76. Guzzetta PC, Potter BM, Ruley EJ, Majd M, Bock GH Renovascular hypertension in children: current concepts in evaluation and treatment. J Pediatr Surg 1989, 24:1236-1249.
77. Harshfield GA, Alpert BS, Pulliam DA Renin-angiotensin-aldosterone system in healthy subjects aged ten to eighteen years. J Pediatr 1993, 122:563-567.
78. Lenders JWM, Pacak K, Walther MM, Linehan WM, et al. Biochemical diagnosis of pheochromocytoma. Which test is best?. JAMA 2002, 287:1427-1434.
79. Weise M, Merke DP, Pacak K, Walther MM, Eisenhofer G Utility of plasma free metanephrines for detecting childhood pheochromocytoma. J Clin Endocrinol Metab 2002, 87:1955-1960.
80. Sakawa AM, Jaeschke R, Singh RJ, Young WF A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab 2003, 88:553-558.
81. Pedersen EB New tools in diagnosing renal artery stenosis. Kidney Int 2000, 57:2657-2677.
82. Dillon MJ The diagnosis of renovascular hypertension. Pediatr Nephrol 1997, 11:366-372.
83. Sahn DJ, DeMaria A, Kisslo J, Weyman A Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978, 58:1072-1083.
84. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986, 57:450-458.
85. de Simone G, Daniels SR, Devereux RB, Meyer RA, et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 1992, 20:1251-1260.
86. de Simone G, Devereux RB, Daniels SR, Koren MJ, et al. Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 1995, 25:1056-1062.
87. Matteucci MC, Wühl E, Picca S, Mastrostefano A, et al. Left ventricular geometry in children with mild to moderate chronic renal insufficiency. J Am Soc Nephrol 2006, 17:218-226.
88. Okin PM, Wright JT, Nieminen MS, Jern S, et al. Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE study. Lorstartan Intervention for Endpoint. Am J Hypertens 2002, 15:663-671.
89. Keith NM, Wagener HP, Barkere NW Some different types of essential hypertension: their course and prognosis. Am J Med Sci 1939, 197:332-343. (also 197: 332-43, 1974).
90. Raczynska K, Potaz P, Aleszewicz-Baranowska J [Epidemiology of hypertensive retinopathy in young patients after coarctation of the aorta repair]. Klin Oczna 2004, 106:456-459.
91. Svardsudd K, Wedel H, Aurell E, Tibblin G Hypertensive eye ground changes. Prevalence, relation to blood pressure and prognostic importance. The study of men born in 1913. Acta Med Scand 1978, 204:159-167.
92. Daniels SR, Lipman MJ, Burke MJ, Loggie JM Determinants of retinal vascular abnormalities in children and adolescents with essential hypertension. J Hum Hypertens 1993, 7:223-228.
93. Skalina ME, Annable WL, Kliegman RM, Fanaroff AA Hypertensive retinopathy in the newborn infant. J Pediatr 1983, 103:781-786.
94. Raitakari OT, Juonala M, Kähönen M, Taittonen L, et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood. The Cardiovascular Risk in Young Finns Study. JAMA 2003, 290:2277-2283.
95. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, et al. Carotidartery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 1999, 340:14-22.
96. Davis PH, Dawson JD, Mahoney LT, Lauer RM Increased carotid intima-medial thickness and coronary calcification are related in young and middle-aged adults: the Muscatine Study. Circulation 1999, 100:838-842.
97. Litwin M, Wühl E, Jourdan C, Trelewicz J, et al. Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation. J Am Soc Nephrol 2005, 16:1494-1500.
98. Litwin M, Trelewicz J, Wawer Z, Antoniewicz J, et al. Intima-media thickness and arterial elasticity in hypertensive children: controlled study. Pediatr Nephrol 2004, 19:767-774.
99. Lande MB, Carson NL, Roy J, Meagher CC Effects of childhood primary hypertension on carotid intima media thickness. A matched controlled study. Hypertension 2006, 48:40-44.
100. Mogensen CE, Christensen CK Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984, 311:89-93.
101. Parving HH, Oxenboll B, Svendsen PA, Christansen JS, Andersen AR Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion. Acta Endocrinol (Copenh) 1982, 100:550-555.
102. Varda NM, Gregoric A A diagnostic approach for the child with hypertension. Pediatr Nephrol 2005, 20:499-506.
103. Bigazzi R, Bianchi S, Baldari D, Campese VM Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension. J Hypertens 1998, 16:1325-1333.
104. Schrader J, Luders S, Kulschewski A, Hammersen F, et al. Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective long-term study (MARPLE Study). J Hypertens 2006, 24:447-449.
105. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998, 351(9118):1755-1756.
106. Flynn JT Evaluation and management of hypertension in childhood. Prog Pediatr Cardiol 2001, 12:177-188.